Business Description
DSM-Firmenich AG
ISIN : CH1216478797
Total Employee Number:
26,983Compare
Compare
Traded in other countries / regions
DSFIR.Netherlands0AC9.UKDSFIY.USADSFIR.SwitzerlandDSFI.AustriaZX6.GermanyDSFIR N.Mexico IPO Date
2025-09-05Description
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 1.82 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.15 | |||||
Beneish M-Score | -3.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.9 | |||||
3-Year EBITDA Growth Rate | 37.6 | |||||
3-Year EPS without NRI Growth Rate | -17 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.36 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 167.64 | |||||
Days Sales Outstanding | 91.3 | |||||
Days Payable | 119.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.6 | |||||
Shareholder Yield % | 4.54 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.18 | |||||
Operating Margin % | 6.84 | |||||
Net Margin % | -15.72 | |||||
EBITDA Margin % | 40.95 | |||||
ROE % | -7.43 | |||||
ROA % | -4.63 | |||||
ROIC % | 1.88 | |||||
ROC (Joel Greenblatt) % | 9.09 | |||||
ROCE % | 2.77 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.53 | |||||
PB Ratio | 1.26 | |||||
Price-to-Tangible-Book | 8.66 | |||||
Price-to-Free-Cash-Flow | 29.1 | |||||
Price-to-Operating-Cash-Flow | 13.95 | |||||
EV-to-EBIT | 37.78 | |||||
EV-to-Forward-EBIT | 29.64 | |||||
EV-to-EBITDA | 7.27 | |||||
EV-to-Forward-EBITDA | 15.04 | |||||
EV-to-Revenue | 2.98 | |||||
EV-to-Forward-Revenue | 2.86 | |||||
EV-to-FCF | 33.93 | |||||
Price-to-GF-Value | 1.08 | |||||
Earnings Yield (Greenblatt) % | 2.65 | |||||
FCF Yield % | 3.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DSM-Firmenich AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 89.4 - 90.24 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DSM-Firmenich AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DSM-Firmenich AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-12 09:00 | In 175 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 174 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 69 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 09:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-07-30 | -- | ||
| General meeting for 2026 | 2026-05-07 | -- | ||
| Annual report for 2025 | 2026-02-23 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 09:00 | -- | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | -- | ||
| Third quarter earnings results for 2025 | 2025-10-30 | -- |
Show
Entries
DSM-Firmenich AG Frequently Asked Questions
What is DSM-Firmenich AG(XTER:ZX6)'s stock price today?
The current price of XTER:ZX6 is €90.20. The 52 week high of XTER:ZX6 is €90.24 and 52 week low is €89.40.
When is next earnings date of DSM-Firmenich AG(XTER:ZX6)?
The next earnings date of DSM-Firmenich AG(XTER:ZX6) is 2026-10-30 Est..
Does DSM-Firmenich AG(XTER:ZX6) pay dividends? If so, how much?
DSM-Firmenich AG(XTER:ZX6) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DSM-Firmenich AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers